🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. We hypothesise that CKDu patients will have increased arterial stiffness...
Status
Completed
Location
Teaching Hospital Anuradhapura
Start Date
2014-09
Trial ID
NCT02226055
Treatments Being Tested
This study aims to implement two interventions to determine the most effect...
Status
Not Yet Recruiting
Location
Danfa Community
Start Date
2026-10-01
Trial ID
NCT07745517
Research questions i) How should electronic frailty index (eFI) components...
Status
Unknown
Location
Multiple Locations
Start Date
2015-01-01
Trial ID
NCT04113174
Treatments Being Tested
Public health programs and policies have utilized the "combination preventi...
Status
Withdrawn
Location
Albert Einstein College of Medicine
Start Date
2013-09
Trial ID
NCT01850576
Treatments Being Tested
The purpose of the study is to see if our education materials help people a...
Status
Recruiting
Location
UAB
Start Date
2025-09-15
Trial ID
NCT07106359
Treatments Being Tested
Postpartum hemorrhage (PPH) remains one of the leading causes of maternal m...
Status
Unknown
Location
Ch Aurillac
Start Date
2019-03-01
Trial ID
NCT03840889
Treatments Being Tested
The goal of this clinical trial is to learn if a behavioral "nudge" strateg...
Status
Completed
Location
Harbin Medical University
Start Date
2025-04-27
Trial ID
NCT07682220
Treatments Being Tested
This randomized controlled trial aims to evaluate the impact of pre-test vi...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2017-11-21
Trial ID
NCT03328091
Treatments Being Tested
CRC patients were enrolled and asked about their FDR contacts These FDRs we...
Status
Completed
Location
Ramanthibodi Hospital
Start Date
2022-09-01
Trial ID
NCT06242197
Treatments Being Tested
The purpose of this study is to explore risk factors for grade 4 neutropeni...
Status
Completed
Location
Pfizer New York
Start Date
2024-08-19
Trial ID
NCT05709158